Project Details
Description
A Phase I/II Study of NB1011 Administered Intravenously by Continuous Infusion in an Every Second Week Regimen with Open-label Continuation in Cancers that Overexpress th
| Status | Finished |
|---|---|
| Effective start/end date | 1/30/06 → 12/31/10 |
Funding
- CELMED BIOSCIENCES, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.